US Exempts India and 19 Countries from Tariffs on Certain Speciality Drugs
The US Commerce Department announced it will exempt certain speciality drugs and related ingredients imported from India and 19 other countries from a planned 100% tariff on patented pharmaceuticals starting September 29. The zero-tariff applies to drugs for rare diseases, infertility, cell and gene therapies, antibody-drug conjugates, and animal pharmaceuticals, along with their components. This exemption is linked to trade and security agreements and aims to encourage domestic pharmaceutical production while maintaining access to critical treatments.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 43/100.
Outlets measured: freepressjournal, hindustantimes, moneycontrol, economictimes, deccanherald, indiatoday, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 28 Sept, 04:00 pm. Other outlets followed.